STOCK TITAN
  1. Home
  2. News
  3. 2026-10-24

Stock Market News for October 24, 2026

23 stories published on Saturday, October 24, 2026.

The day runs on New York time, and each time in the list shows the time zone it is in.

US stock markets are closed on this day. News from the last trading session is on Friday, October 23, 2026.

RSS Feed Add StockTitan on Google Add to Google Follow on Google News
Fri, Oct 23 Sun, Oct 25
IMPACT
SENTIMENT
GXRFF : OTC
Prospera Energy Announces Service Rig Update as Luseland Workovers Come Online at 3.3x Prior Rates
penny stock
IMPACT
SENTIMENT
ELEK : OTC
From Record-High Market Excitement to American Lithium Ambition: Elektros Looks North
penny stock
IMPACT
SENTIMENT
CLYM : Nasdaq
Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
clinical trial
IMPACT
SENTIMENT
GGII : OTC
Siren's Tale Vodka to Exhibit at SoCal Cocktail and Spirits Fest
penny stock
IMPACT
SENTIMENT
AXON : Nasdaq
Axon Announces Body 5: Next-Generation Camera Built for the AI Era
AI
IMPACT
SENTIMENT
PFE : NYSE
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
clinical trial
IMPACT
SENTIMENT
AZN : NYSE
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
clinical trial
IMPACT
SENTIMENT
AMGN : Nasdaq
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
IMPACT
SENTIMENT
AZN : NYSE
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
IMPACT
SENTIMENT
DRI : NYSE
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Darden Restaurants, Inc. for Alleged Failure to Reimburse Employees' Business Expenses
IMPACT
SENTIMENT
JNJ : NYSE
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
IMPACT
SENTIMENT
PBLS : Nasdaq
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
clinical trial
IMPACT
SENTIMENT
BAYRY : OTC BAYZF : OTC
ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence
IMPACT
SENTIMENT
SMTC : Nasdaq
Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026
IMPACT
SENTIMENT
GMAB : Nasdaq INCY : Nasdaq
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
clinical trial
IMPACT
SENTIMENT
NBTX : Nasdaq
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
clinical trial
IMPACT
SENTIMENT
ONC : Nasdaq
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
IMPACT
SENTIMENT
CMPX : Nasdaq
Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
clinical trial high short penny stock
IMPACT
SENTIMENT
CELC : Nasdaq
Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
clinical trial high short
IMPACT
SENTIMENT
LLY : NYSE
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026
clinical trial
IMPACT
SENTIMENT
IMTX : Nasdaq
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
IMPACT
SENTIMENT
ZYME : Nasdaq
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
clinical trial
IMPACT
SENTIMENT
LAWR : Nasdaq
Robot Consulting Announces Receipt of Nasdaq Delisting Determination and Request to Appeal such Determination Before a Hearings Panel
low float
Fri, Oct 23 Sun, Oct 25

You can use the feed to follow a portfolio or watchlist, research a company, or catch up on developments around shares you own.

It keeps the day's company news in one place, with the dated archive available when you need an earlier session.

What this page covers